http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108158975-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
filingDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108158975-B |
titleOfInvention | Graphene oxide nano silver terbinafine antifungal slow-release temperature-sensitive gel and preparation method and application thereof |
abstract | The invention provides graphene oxide nano silver terbinafine antifungal slow-release temperature-sensitive gel and a preparation method and application thereof. In the graphene oxide nano silver terbinafine antifungal slow-release temperature-sensitive gel, graphene oxide is used as a drug slow-release carrier, so that the drug release and action time is prolonged; meanwhile, the loaded nano silver can continuously release silver ions to assist in enhancing the antifungal effect, and due to the special sterilization mechanism of the silver ions, the problem of drug resistance is avoided, and the recurrence probability is low; similarly, poloxamer is used as an adjuvant, so that the medicine is in a liquid state at normal temperature, and becomes gel due to temperature rise when being applied to an affected part, so that the medicine is convenient to administer, and the contact time of the medicine and the affected part can be prolonged. |
priorityDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.